STOCK TITAN

RadNet (RDNT) chief strategy officer exercises 62,964 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RadNet, Inc. director and Chief Strategy Officer Alma Gregory Sorensen exercised previously granted employee stock options on March 10, 2026 to acquire 62,964 shares of common stock. These options were originally granted in connection with retention of employment at DeepHealth, Inc., a wholly owned subsidiary of RadNet, with vesting over several years.

Following the exercises, Sorensen directly holds 1,244,842 shares of RadNet common stock. The transactions reflect compensation-related option exercises rather than open-market buying or selling.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sorensen Alma Gregory

(Last) (First) (Middle)
C/O RADNET, INC.
1510 COTNER AVENUE

(Street)
LOS ANGELES CA 90025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RadNet, Inc. [ RDNT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Strategy Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/10/2026 M 3,742 A $0 1,185,620(1) D
Common Stock 03/10/2026 M 4,987 A $0 1,190,607(1) D
Common Stock 03/10/2026 M 6,237 A $0 1,196,844(1) D
Common Stock 03/10/2026 M 7,481 A $0 1,204,325(1) D
Common Stock 03/10/2026 M 8,727 A $0 1,213,052(1) D
Common Stock 03/10/2026 M 12,466 A $0 1,225,518(1) D
Common Stock 03/10/2026 M 2,493 A $0 1,228,011(1) D
Common Stock 03/10/2026 M 16,831 A $0 1,244,842(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $0 03/10/2026 M 3,742 04/01/2019(2) 07/10/2028 Common Stock 3,742 $0 0 D
Employee Stock Option (right to buy) $0 03/10/2026 M 4,987 07/01/2019(2) 09/30/2028 Common Stock 4,987 $0 0 D
Employee Stock Option (right to buy) $0 03/10/2026 M 6,237 10/01/2019(2) 03/09/2029 Common Stock 6,237 $0 0 D
Employee Stock Option (right to buy) $0 03/10/2026 M 7,481 01/01/2020(2) 06/14/2029 Common Stock 7,481 $0 0 D
Employee Stock Option (right to buy) $0 03/10/2026 M 8,727 04/01/2020(2) 07/31/2029 Common Stock 8,727 $0 0 D
Employee Stock Option (right to buy) $0 03/10/2026 M 12,466 07/01/2020(2) 10/16/2029 Common Stock 12,466 $0 0 D
Employee Stock Option (right to buy) $0 03/10/2026 M 2,493 07/01/2020(2) 10/19/2029 Common Stock 2,493 $0 0 D
Employee Stock Option (right to buy) $0 03/10/2026 M 16,831 10/01/2020(2) 01/12/2030 Common Stock 16,831 $0 0 D
Explanation of Responses:
1. Exercise of previously granted option.
2. The reporting person was previously granted options in connection with retention of employment with DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc. Twenty-five percent of the options vested on the date exercisable, and the remaining options vest in equal monthly installments over the succeeding three years.
/s/ Jose Gamez, Attorney-in-Fact 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did RadNet (RDNT) report for Alma Gregory Sorensen?

RadNet reported that Alma Gregory Sorensen exercised employee stock options to acquire 62,964 shares of common stock on March 10, 2026. These were previously granted options linked to employment retention at DeepHealth, Inc., a wholly owned RadNet subsidiary, with multi-year vesting.

How many RadNet (RDNT) shares does Alma Gregory Sorensen now own?

After the reported option exercises, Alma Gregory Sorensen directly owns 1,244,842 shares of RadNet common stock. This figure reflects the cumulative effect of multiple derivative exercises converting options into common shares on March 10, 2026.

Were the RadNet (RDNT) Form 4 transactions open-market purchases or sales?

The Form 4 for RadNet shows no open-market buys or sells. Instead, Alma Gregory Sorensen exercised previously granted employee stock options, converting them into 62,964 common shares as compensation-related transactions, without any reported sale of shares in the market.

What was the purpose of the options exercised by Alma Gregory Sorensen at RadNet (RDNT)?

The options exercised by Alma Gregory Sorensen were retention grants tied to employment with DeepHealth, Inc., RadNet’s wholly owned subsidiary. Footnotes explain that 25% vested at the exercisable date and the remainder vested in equal monthly installments over three years.

How many employee stock options did Alma Gregory Sorensen exercise at RadNet (RDNT)?

Alma Gregory Sorensen exercised employee stock options covering 62,964 underlying shares of RadNet common stock. The filing’s transaction summary reports an exerciseCount of eight derivative transactions totaling 62,964 option shares converted into common shares on March 10, 2026.

What role does Alma Gregory Sorensen hold at RadNet (RDNT)?

Alma Gregory Sorensen is identified as a director and Chief Strategy Officer of RadNet, Inc. The Form 4 lists Sorensen as both a director and officer, with the officer title specifically disclosed as Chief Strategy Officer in the reporting person information.
Radnet

NASDAQ:RDNT

View RDNT Stock Overview

RDNT Rankings

RDNT Latest News

RDNT Latest SEC Filings

RDNT Stock Data

4.74B
66.81M
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES